{"id":234948,"date":"2026-04-10T10:13:03","date_gmt":"2026-04-10T15:13:03","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2026\/04\/mitochondria-power-immunity-against-cancer"},"modified":"2026-04-10T10:13:03","modified_gmt":"2026-04-10T15:13:03","slug":"mitochondria-power-immunity-against-cancer","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2026\/04\/mitochondria-power-immunity-against-cancer","title":{"rendered":"Mitochondria power immunity against cancer"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/mitochondria-power-immunity-against-cancer2.jpg\"><\/a><\/p>\n<p>Dendritic cells are innate immune cells that regulate the quality, magnitude, and duration of antitumor responses.<\/p>\n<p>Conventional type 1 dendritic cells (cDC1s) are crucial in this capacity but are paradoxically rare and functionally impaired in most solid tumors. This is a major barrier to effective immunotherapy. The molecular underpinnings of cDC1 dysfunction within the tumor microenvironment are poorly understood.<\/p>\n<p>In a new <i>Science<\/i> study, researchers report that mitochondrial fitness is important for cDC1 function. They also demonstrate the therapeutic rescue of cDC1 function within the tumor microenvironment in mice, which provides a framework for metabolically reprogramming dendritic cells to restore antitumor immunity.<\/p>\n<p>Learn more in a new <i>Science<\/i> Perspective.<\/p>\n<hr>\n<p>A subset of dendritic cells relies on mitochondrial fitness to trigger antitumor responses in mice.<\/p>\n<p><a href=\"https:\/\/www.science.org\/doi\/10.1126\/science.aeg4325#con1\"> Irene S. Molina<\/a> and <a href=\"https:\/\/www.science.org\/doi\/10.1126\/science.aeg4325#con2\"> Malay Haldar<\/a> <a href=\"https:\/\/www.science.org\/doi\/10.1126\/science.aeg4325#tab-contributors\">Authors Info &amp; Affiliations<\/a><\/p>\n<div class=\"more-link-wrapper\"> <a class=\"more-link\" href=\"https:\/\/lifeboat.com\/blog\/2026\/04\/mitochondria-power-immunity-against-cancer\">Continue reading \u201cMitochondria power immunity against cancer\u201d | &gt;<\/a><\/div><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Dendritic cells are innate immune cells that regulate the quality, magnitude, and duration of antitumor responses. Conventional type 1 dendritic cells (cDC1s) are crucial in this capacity but are paradoxically rare and functionally impaired in most solid tumors. This is a major barrier to effective immunotherapy. The molecular underpinnings of cDC1 dysfunction within the tumor [\u2026]<\/p>\n","protected":false},"author":662,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11],"tags":[],"class_list":["post-234948","post","type-post","status-publish","format-standard","hentry","category-biotech-medical"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/234948","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/662"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=234948"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/234948\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=234948"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=234948"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=234948"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}